spacer   Search       
INSIDE AFRO
AFRO NEWS

Black Woman-Owned Business Receives Local Recognition

Last Updated Apr 2008


By Ashley D. Diggs

Special to the AFRO

ROCKVILLE, Md. – Women business owners Dr. Loleta Robinson and Colleen Nye of Syan Biosciences tied for third place with Jessica Feltz of The Turning Point at the fifth annual Women-In-Business and StartRight! business plan competition in Rockville on April 1.  StartRight!, developed by Rockville Economic Development Inc. (REDI) is a local competition held each year to award women who have potentially successful business plans for their recently established businesses.  REDI was established to strengthen and broaden the economic development of Rockville by helping existing businesses and new companies start, grow, finance and manage their organizations. Other winners, Lisa Chan of ZaraCom Technologies won first place and Sharon Flank of InfraTrac placed second.

Loleta Robinson, 36, the only Black woman to succeed in the April 1 competition, wants to develop “the next generation of medicine.”

“The market is competitive, but I’m here to improve some of its products,” she said.  Robinson’s award-winning “Lab-on-a-Chip” commercialized technology platform converts laboratory functions onto a small chip for diagnostic testing for heart disease and cancer, water and food analysis, and chemical biological agent detection.  Prototype, the initial product of “Lab-on-a Chip” is a research based assay test kit that will later become a hand held device for diagnostics. 

“The opportunity for women entrepreneurs in this area is increasing,” Robinson said. “Women business owners basically formed their own community.”

 After earning degrees in medicine and in business, she decided to take the entrepreneurial path.  “I saved every dollar and tax refund check since 2002,” she said, to begin her Baltimore-based company, Syan Biosciences.  With assistance from government grants and state funds, Robinson can continue to develop Prototype.  Once “Lab-on-a-Chip” is fully advanced, it can be sold to hospitals, clinical labs, academic institutions, physicians' offices, acute care centers and other biotechnology pharmaceutical companies.

Third place winners received an estimated $1,200 and three months of virtual, customized office resources.  Robinson says the winnings will aid with early product development for Prototype.  The expected completion date for phase one, a research-only diagnostic kit for heart disease and cancer is 2011.   

Rate this:
Recent Comments
There are currently no comments. Be the first to make a comment.

 


 
     Terms Of Use      Privacy Statement